Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Histamine H3 antagonist ciproxifan shows positive behavioral effects in animal models

Jan. 8, 1999

Mexiletine effectively controls spasmodic torticollis in treatment-refractory patients

Jan. 8, 1999

Diatide receives patent protection for novel cancer pain treatment

Jan. 8, 1999

Remacemide provides neuroprotection during CPB

Jan. 7, 1999

Interneuron receives milestone payment from Lilly under Prozac agreement

Jan. 7, 1999

Fujisawa obtains Japanese marketing rights to Zeneca's atypical antipsychotic quetiapine

Jan. 7, 1999

Nonpsychoactive, neuroprotective cannabinoids available for licensing from NIH

Jan. 7, 1999

Mayo Clinic closes in on gene causing PD and essential tremor

Jan. 5, 1999

Second phase II trial commences for SIB-1508Y

Jan. 5, 1999

CytoTherapeutics granted U.S. patent covering human neural stem cells

Jan. 5, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...